LLY · 10-Q · 2026Q3 · Full report
Manufacturing Capacity
ELI LILLY & Co · 2026-10-29 · Importance 40 · Surprise 42 · In source text
Lilly has undertaken significant manufacturing expansion initiatives to support anticipated demand for current and prospective products. Additional capacity is expected to become operational over the next several years. The filing does not quantify the capacity additions or specify utilization rates.
Key facts
- Lilly has undertaken significant manufacturing expansion initiatives to support anticipated demand for current and prospective products; additional capacity is expected to become operational over the next several years. source
- Lilly's investments in global manufacturing facilities and other capital investments have increased capital expenditures and are expected to result in higher capital expenditures in the near term. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | Lilly has undertaken significant manufacturing expansion initiatives to support anticipated demand for current and prospective products;… |